ALLERGIC RHINITIS: ATTESTATION
|
|
- Osborn Payne
- 5 years ago
- Views:
Transcription
1 Allergic Rhinitis Treatment Guidelines ALLERGIC RHINITIS: ATTESTATION. Effective Date: December 28, 2009 Reasn fr Attestatin: Annual review and update f existing guideline Key Guideline Updates/Revisins: Additin f fllwing treatment ptins -- Azelastine hydrchlride (Astepr) Mntelukast (Singulair) fr sme patients with asthma
2 Allergic Rhinitis Treatment Guidelines page 2 f 9 ALLERGIC RHINITIS Allergic rhinitis is an IgE-mediated inflammatry disease invlving the nasal mucsa membranes in which symptms result frm a cmplex allergen-driven mucsal inflammatin and may be characterized by early-phase and late-phase respnses. Symptms may be episdic, seasnal r perennial. Repeated expsures ( priming ) may result in a slwer rate f symptm reslutin. Allergic cnjunctivitis is frequently a cmrbidity with allergic rhinitis (see Cnjunctivitis guideline). Refer Out Less than 2 years ld Currently taking ral sterids fr severe allergic reactin Currently taking allergen immuntherapy Asthmatics with exacerbatin symptms (see Asthma Mnitring guideline) Differential Diagnsis Viral Upper Respiratry Illness (use VURI guideline) Gradual nset f symptms f general malaise, laryngitis, injectin f the cnjunctiva, and headache Vasmtr rhinitis (Idipathic rhinitis) Persistent nasal cngestin that des nt have a crrelatin t specific allergen expsures with rapid nset f nasal cngestin and nticeable pstnasal drip Atrphic rhinitis nasal airways are clear, mucsa is dry Rhinitis medicamentsa rebund nasal cngestin due t persistent nasal decngestant use Bacterial sinusitis (use Sinusitis guideline) Freign bdy Deviated septum Nasal plyps Assciated with nasal cngestin, rhinrrhea and ansmia Nasal r sinus tumrs/cancer -- Symptms may include recent nset gastresphageal reflux (GERD), pain, decreased sensatin f face, palate, teeth Clinical Presentatin Patient may cmplain f: Nasal cngestin, sneezing and clear rhinrrhea r pstnasal drainage, chrnic sniffling Itching f the nse, eyes, palate, and ears
3 Allergic Rhinitis Treatment Guidelines page 3 f 9 Cughing (may be mre prevalent in the mrning) Sre/scratchy thrat r itchy palate Sinus pressure Puffiness, redness, and watering f eyes may ccur Reprt sensitivity t specific allergen: dust, pllen, mld, etc. Seasnal, perennial r episdic symptms Family histry f allergies On exam: Pale, bggy nasal mucsa with clear thin secretins Enlarged nasal turbinates which may bstruct airway flw, Muth-breathing (allergic gape) Allergic shiners, perirbital edema, cbblestne appearance f the cnjunctiva with erythema Dennie s lines (lwer eyelid creases) Nasal salute Enlarged tnsils and adenids, pharyngeal cbblestne appearance Treatment Optins ($ = <$25, $$ = $25-50, $$$ = $50-100, $$$$ = $ , $$$$$ = >$150)
4 Allergic Rhinitis Treatment Guidelines page 4 f 9 Treatment Optin Advantages Disadvantages Nasal Saline Imprves mucus clearance Nne Enhances ciliary beat activity Remves antigens, bifilm r inflammatry mediatrs May prvide prtective effect n sin-nasal mucsa Intranasal Mst effective mntherapy Onset f actin may be up t Crticsterids First line fr mderate t severe 12 hurs (INS) (e.g., symptms Maximum efficacy may nt be Fluticasne) Effective in cntrlling sneezing, itching, rhinrrhea, and nasal cngestin achieved fr up t 2 weeks cnsider cncmitant use f ral antihistamines Secnd generatin ral antihistamines (e.g., lratadine) Preferred ver 1 st generatin t minimize sedatin, perfrmance impairment, and antichlinergic effects Cnsider fr patients unable r unwilling t use INS May be used alne in mild and episdic AR Nne Treatment Optin Advantages Disadvantages Intranasal Significant rapid nset f actin Less effective than INS fr Antihistamines Apprpriate fr use in episdic AR nasal symptms (e.g., Azelastine) Effectiveness equal t r superir t ral 2 nd generatin antihistamines with clinically significant effect n nasal cngestin Bitter taste Oral Decngestants (e.g., pseudephedrine) Leuktriene receptr antagnists (LTRA) (e.g., Mntelukast) Reduces nasal cngestin May be used in cmbinatin with antihistamines fr mre effective relief f nasal cngestin than with an antihistamine alne N significant difference in efficacy between LTRA and ral antihistamines Cmbinatin therapy with an antihistamine may prvide an alternative treatment fr patients with cmrbid asthma wh are unrespnsive t r nt cmpliant with INS Cmbinatin prducts (antihistamine/decngestants like Allegra-D) d nt prvide the ability t discntinue ne r the ther as symptms imprve. Many cmbinatin have replaced pseudephedrine with phenylephrine Efficacy f phenylephrine has nt been well established Less effective than INS Reprted neurpsychiatric events with these drugs have included agitatin, aggressin, anxiusness, irritability, restlessness and insmnia. Patients have als experienced tremrs, dream abnrmalities, hallucinatins, depressin and suicidality, including suicide.
5 Allergic Rhinitis Treatment Guidelines page 5 f 9 Antihistamine r Dsing Frequency Cnsideratins/ Pregnancy Categry Lratadine (e.g., Claritin) ($) 6 years and adults: 10mg by muth nce a day 2-5 years: 5 mg by muth nce a day Categry B Cetirizine (e.g., Zyrtec) ($) 12 years and adults: 10mg by muth nce a day 6-11 years: 5mg by muth nce a day Categry B Nt recmmended fr nursing mthers 2-5 years (use liquid): 2.5mg (2.5 ml) by muth nce a day May be mre sedating than lratadine Chlrpheniramine ($) 12 years and adults: 4mg by muth every 4-6 hurs (Max 24mg/24hurs) 6-11 years: 2 mg by muth every 4-6 hurs (Max 12mg/24 hurs) 2-5 years: 1 mg by muth every 4-6 hurs (Max 4mg/24 hurs) Categry B Preferred drug during the first trimester May cause sedatin/drwsiness first generatin antihistamine Antihistamine r Dsing Frequency Cnsideratins/ Pregnancy Categry Fexfenadine (e.g., Allegra) (60 mg $$; 180mg $$$) 12 years and adults: 60mg by muth tw times a day r 180mg by muth nce a day 6-11 years: 30mg by muth tw times a day 2-5 years: 30 mg (5 ml) by muth tw times a day Categry C Suspensin recmmended fr <6 years ld 30 day supply May refill x 2 Deslratadine (e.g., Clarinex) ($$$$) 12 years and adults: 5mg by muth nce a day 6 11 years: 2.5 mg by muth nce a day 2 5 years (use syrup): 1.25 mg (2.5mL) by muth nce a day Categry C Nt recmmended fr nursing mthers 30 day supply May refill x 2 Azelastine (Astepr) ($$$) Azelastine (Astellin) ($$$$) 12 years and adults: 1-2 sprays in each nstril tw times a day 12 years and adults: 1-2 sprays in each nstril tw times a day 5-11 years: 1 spray in each nstril tw times a day Categry C Intranasal antihistamine, nt sterid 137 mcg/inhalatin nasal spray 30 day supply May refill x2
6 Allergic Rhinitis Treatment Guidelines page 6 f 9 Intranasal Crticsterid Sprays (30 day supply; May refill x2) Intranasal Crticsterid Fluticasne (Flnase) 0.05 mg/inh Intranasal Spray ($$) Mmetasne (Nasnex) 50 mcg/inh Intranasal Spray ($$$) Triamcinlne (Nasacrt AQ) 55 mcg/inh Intranasal Spray ($$$) Dsing Frequency 12 years and adults: 2 sprays in each nstril nce a day 4-11 years: 1 spray in each nstril daily 12 years and adults: 2 sprays in each nstril nce a day 2-11 years: 1 spray in each nstril daily 13 years and adults: 2 sprays in each nstril nce a day 6-12 years: 1-2 spray in each nstril daily 2-5 years: 1 spray in each nstril daily Pregnancy Categry Categry C Categry C Categry C
7 Allergic Rhinitis Treatment Guidelines page 7 f 9 Intranasal Crticsterid Budesnide (Rhincrt AQ) 32 mcg/inh Intranasal Spray ($$$$) Dsing Frequency 13 years and adults: 1 t 4 sprays in each nstril nce a day 6-12 years: 1-2 sprays in each nstril nce a day Pregnancy Categry Categry B Other Optins Medicatin Dsing Cnsideratins Pregnancy categry C Pseudephedrine ($) Oxymetazline ($) Nasal Saline Crmlyn Sdium ($) 18 years: 60 mg (immediate release) every 6 hurs as needed r 120 mg (sustained release) every 12 hurs as needed years: 1 mg/kg PER DOSE every 6 hurs as needed; d nt exceed 60 mg per dse r 240 mg per day Age 6 years -- 2 sprays bth nstrils every 12 hurs fr n mre than 3 days Nasal wash (e.g., Sinus Rinse r generic) Use 2 times a day, as needed Saline spray (e.g., Ocean, Ayr r generic) every 2 hurs while awake fr patients wh are reluctant t use nasal wash 2 years: ne spray t each nstril every 4-6 hurs Fr relief f nasal cngestin All studies regarding efficacy perfrmed using 240 mg daily dsage D nt use in patients with cmrbid cardiac r crnary artery cnditins D nt use in patients with histry f hypertensin r bld pressure reading abve 135/85 mm Hg Pregnancy categry C Fr relief f nasal cngestin May be used with cautin if HTN well-cntrlled <135/85 Gd ptin fr thse wh cannt take INS but less effective than INS Mst effective when started befre symptms begin; nset f actin 4-7 days Pregnancy categry B; cautin in nursing mthers
8 Allergic Rhinitis Treatment Guidelines page 8 f 9 Leuktriene Inhibitr fr patients with asthma cmrbidity wh are unrespnsive t r nn-cmpliant with INS Mntelukast (Singulair) ($$$$) 15 years t Adult: 10mg by muth nce a day in the evening 6-14 years: 5mg by muth nce a day in the evening 2-5 years: 4mg by muth nce a day in the evening Pregnancy categry B If initiating treatment (patient has never been n Mntelukast) recmmend fllwing up in 2 weeks at MC r a primary care prvider t evaluate effectiveness and any side effects that may have presented. Patient Educatin Envirnmental cntrl measures fr pllens, fungi/mlds, dust mites, pet dander, and insects. Minimize expsure t ther irritants like smke, perfumes, csmetics, hair spray, and ther drs Suggest develpment f a rhinitis actin plan that includes what medicatins t use fr specific symptms and when t seek medical attentin in cnjunctin with Primary Care Prvider Prvide instructins n use f intranasal sprays (Key pints) Shake the bttle well Blw nse until clear befre administering medicatin Tilt head slightly frward, place the nasal applicatr int the nstril making sure t keep the bttle upright ( Lk at yur tes and spray yur nse ) Breathe nrmally when spraying the medicatin Wipe the applicatr with a clean tissue after use Fllw-Up Seek immediate medical attentin fr difficulty breathing, wheezing, shrtness f breath, chest discmfrt. Fllw up with MinuteClinic r primary care prvider in 14 days if n imprvement in symptms. Initiatin f Mntelukast: Fllw up with MinuteClinic r primary care prvider in 2 weeks t evaluate effectiveness and any side effects that may have develped.
9 Allergic Rhinitis Treatment Guidelines page 9 f 9 References 1. ARIA At-A-Glance Pcket Reference. 1 st ed Available: 2. Bruntn SA, Frmer LM. Treatment ptins fr the management f perennial allergic rhinitis, with a fcus n intranasal crticsterids. Suthern Medical Jurnal. 2007;100(7): Heier B, Ortiz G, Williams DM. The rle f nnprescriptin antihistamines in the treatment f allergic rhinitis. Washingtn, DC: American Pharmacists Assciatin Institute fr Clinical Systems Imprvement. Health care guideline: diagnsis and treatment f respiratry illness in children and adults. Blmingtn, MN: Authr, Jan Quillen DM, Feller DB. Diagnsing rhinitis: Allergic vs. nnallergic. American Family Physician. 2006;73(9): Wallace DV, Dykewicz MS, eds. The diagnsis and management f rhinitis: An updated practice parameter. Jurnal f Allergy and Clinical Immunlgy August (Suppl);122(2):S1-S Wrld Health Organizatin (WHO). Allergic rhinitis and its impact n asthma. Natinal Guideline Clearinghuse Yawn B, Knudtsn M. Treating asthma and cmrbid allergic rhinitis in pregnancy: A review f the current guidelines. Jurnal f the American Bard f Family Medicine. 2007;20(3):
This table cannot be relied upon in the absence of: PA Medical Directive #4 Otolaryngology
Title and Number f Directive: Order Table PA-4: Otlarynglgy This table cannt be relied upn in the absence f: PA Medical Directive #4 Otlarynglgy 1. OVERALL CONDITIONS - The PA may evaluate and prvide care
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is
More informationWhat is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center
A cllabrative effrt f Children s Hspital f Pittsburgh f UPMC and The Pennsylvania Child Welfare Resurce Center What is Asthma? Jennifer E. Wlfrd, DO, MPH, FAAP Children s Hspital f Pittsburgh, Divisin
More informationVaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE
Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationOriginal Policy Date 12:2013
MP 5.01.18 Xlair (Omalizumab) Medical Plicy Sectin Prescriptin Drugs Issu12:2013e 4:2006 Original Plicy Date 12:2013 Last Review Status/Date Lcal plicy/12:2013 Return t Medical Plicy Index Disclaimer Our
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More informationPart 1 describes the reasoning and recommendations up to node 2 of the algorithm.
Presented by: David Osser, MD Assciate Prfessr f Psychiatry Harvard Medical Schl Dr. Osser has n cnflicts f interest t disclse. This dcument is a summary f selected clinical pearls frm Dr. Osser s presentatin:
More informationUS Public Health Service Clinical Practice Guidelines for PrEP
Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationPain relief after surgery
Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read
More informationNew Patient Registration and Medical History. Address City State Zip code
Wexfrd Allergy, Asthma & Immunlgy, LLC Phne (724)719-2441 / Fax (724)719-2451 100 Bradfrd Rad, Suite 410, Wexfrd, PA 15090 www.wexfrdallergy.cm New Patient Registratin and Medical Histry Name Tday s date
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationRoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation
RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits
More informationKey Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.
Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe
More informationNew Zealand Consumer Medicine Information. Tramadol hydrochloride immediate release capsules (50 mg) and solution for injection (50 mg/ml, 100 mg/2ml)
New Zealand Cnsumer Medicine Infrmatin TRAMAL Tramadl hydrchlride immediate release capsules (50 mg) and slutin fr injectin (50 mg/ml, 100 mg/2ml) What is in this leaflet Please read this leaflet carefully
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationPATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.
PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr
More informationKey Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.
Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated
More informationImportant Information
Grup Health Pharmacy Administratin GSE-B2N-02 2921 Naches Ave SW PO Bx 9009 Rentn, WA 98057-9009 Grup Health Cperative Grup Health Optins, Inc. ghc.rg Imprtant Infrmatin February 6, 2017 Dear Prvider,
More informationNew Patient Registration and Medical History. Address City State Zip code
Wexfrd Allergy, Asthma & Immunlgy, LLC Phne (724)719 2441 / Fax (724)719 2451 100 Bradfrd Rad, Suite 410, Wexfrd, PA 15090 www.wexfrdallergy.cm New Patient Registratin and Medical Histry Name Tday s date
More informationYou may have a higher risk of bleeding if you take warfarin sodium tablets and:
MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain
More informationInfluenza (Flu) Fact Sheet
Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder
More informationAsthma inhalers, medicines and treatments
Asthma inhalers, medicines and treatments Reliever inhalers Yur Emergency Rescue Reliever Everyne with asthma shuld ALWAYS carry a reliever (blue inhaler) inhaler at all the time s it s n hand in an emergency
More informationImmunotherapy Guide Increases Dosing Accuracy. Jared Darveaux, MD
Immuntherapy Guide Increases Dsing Accuracy Jared Darveaux, MD Disclsures Nne ON TARGET Backgrund Immuntherapy (IT) is a therapeutic tl used t treat allergic rhinitis and allergic asthma fr decades In
More informationContinuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP
Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit
More informationBP Thresholds for Medical Review
BP Threshlds fr Medical Review Wmen presents t GP pstnatally with high bld pressure r referred t GP by midwife GP t review patient n the same day if BP>150/100. If BP (dne by midwife) persistently 140-149/90-99,
More informationVenom Hypersensitivity
Venm Hypersensitivity Venm Allergy Large lcalised reactin ~ 10% in adults Systemic allergic reactins Up t 3% f adults Severe sting reactins in up t 1% f children In Australia, apprximately 2 fatalities
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationSection 6 Students School District No. 71 (Comox Valley)
Sectin 6 Students Schl District N. 71 (Cmx Valley) Administrative Prcedure 6011 MR2 Allergies and Anaphylaxis 1. Intrductin The Bard f Educatin expects schls t reasnably accmmdate students with medically
More information2017 Optum, Inc. All rights reserved BH1124_112017
1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases
More informationSuicidal thoughts or actions:
MEDICATION GUIDE Venlafaxine (VEN la fax een) Hydrchlride Extended-release Capsules USP Read the Medicatin Guide that cmes with venlafaxine hydrchlride extended-release capsulesbefre yu start taking them
More informationState Medicaid Coverage for Home Visits
Cvered Withut Barriers State Medicaid Cverage fr Hme Visits Cvered Sme Cverage N Cverage States fr which data is nt yet available NH VT MA RI CT NJ DE MD DC: HI Last Updated: June 30, 2016 1 Asthma Guidelines-Based
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationo New or sudden changes in mood, behavior, actions, thoughts, or feelings, especially if severe.
MEDICATION GUIDE FLUOXETINE CAPSULES, USP (fl xʹ e teen) 10 mg and 20 mg Read the Medicatin Guide that cmes with fluxetine capsules befre yu start taking it and each time yu get a refill. There may be
More informationPackage leaflet: Information for the user. CHAMPIX 0.5 mg film-coated tablets CHAMPIX 1 mg film-coated tablets Varenicline
Package leaflet: Infrmatin fr the user CHAMPIX 0.5 mg film-cated tablets CHAMPIX 1 mg film-cated tablets Varenicline Read all f this leaflet carefully befre yu start taking this medicine because it cntains
More informationFrequently asked questions: Influenza A (H1N1)v
July 30 th 2009 V1.0 Frequently asked questins: Influenza A (H1N1)v (Swine Flu) infrmatin fr parents The fllwing advice is fr parents f children in all educatinal institutins, including crèches, childcare,
More informationMEDICATION GUIDE. (Interferon alfa-2b)
MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take
More informationThank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone!
Thank yu fr cmmitting t engage pharmacists regarding the incredible pprtunity fr them t prevent piid verdse deaths by prviding nalxne! If yu encunter cmplicated questins that yu are unable t answer, please
More informationPackage leaflet: Information for the user. GASTROGRAFIN GASTROENTERAL SOLUTION Sodium amidotrizoate and meglumine amidotrizoate
Due t regulatry changes, the cntent f the fllwing Patient Infrmatin Leaflet may vary frm the ne fund in yur medicine pack. Please cmpare the 'Leaflet prepared/revised date' twards the end f the leaflet
More informationProstatitis - chronic - Management
Prstatitis - chrnic - Management Scenari: Diagnsis f chrnic prstatitis Hw shuld I diagnse chrnic prstatitis? Diagnse chrnic prstatitis if: The man has pain in the perineum r pelvic flr and lwer urinary
More informationPennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain
Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre
More informationThis information shows what new challenges are likely to require prevention efforts moving forward.
Release f CDC s Healthcare-Assciated Infectins (HAI) Pint Prevalence Survey and Annual Natinal and State HAI Prgress Reprt Embarged until: Wednesday, March 26 th at 12 nn ET Key Messages Overall These
More informationBedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:
Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign
More informationRequest for Prior Authorization for Click here to enter text. Website Form Submit request via: Fax
Request fr Prir Authrizatin fr Click here t enter text. Website Frm www.highmarkhealthptins.cm Submit request via: Fax - 1-855-476-4158 Updated: 05/2018 DMMA Apprved: 05/2018 All requests fr Intravenus
More informationVaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE
Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationSUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745
Generic Brand HICL GCN Exceptin/Other NALTREXONE CONTRAVE ER 41389 /BUPROPION LORCASERIN BELVIQ 34733 PHENTERMINE PHENTERMINE 20691 20692 20693 20713 PHENTERMINE LOMAIRA 20715 PHENTERMINE/TO PIRAMATE GUIDELINES
More informationo Prostanoids/prostacyclin therapies (oral and inhaled) o Inhaled agents: Ventavis, Tyvaso Page 1 of 5 Revised 02/17/17
Request fr Prir Authrizatin Pulmnary Arterial Hypertensin (PAH) Agents (Oral and Inhaled) Website Frm www.highmarkhealthptins.cm Submit request via: Fax - 1-855-476-4158 All requests fr Pulmnary Arterial
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationTendon problems can happen in people of all ages who take levofloxacin. Tendons are tough cords of tissue that connect muscles to bones.
Medicatin Guide LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION, 25 mg/ml and LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION in 5% Dextrse fr Intravenus Use Read this Medicatin Guide befre yu start taking levflxacin
More informationADULT PHARYNGITIS (SORE THROAT)
Fr mre infrmatin r t prvide feedback n this r any ther decisin supprt tl, email certifiedpractice@bccnp.ca ADULT PHARYNGITIS (SORE THROAT) DEFINITION Inflammatin r infectin f the mucus membranes f the
More informationAccess to Heme Treatment in Canada - Survey 2018
Access t Heme Treatment in Canada - Survey 2018 The Canadian Assciatin fr Prphyria/Assciatin Canadienne de Prphyrie (CAP/ACP) asserts that patients with acute prphyria shuld have access t Hemin treatment,
More informationNEW PATIENT FORMS FOR ADULT. Patient Last Name First Name Middle Name. DOB Age Race SSN. Sex Single Married Widowed Divorced
The Allergy and Asthma Center f Crpus Christi 1718 Braeswd Dr, Crpus Christi TX 78412 text: 361-992-8500 Fax: 361-992-6711 www.allergycrpustx.cm NEW PATIENT FORMS FOR ADULT Patient Last Name First Name
More informationCLINICAL MEDICAL POLICY
Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019
More informationPediatric Health History Form
Pediatric Health Histry Frm Child s Name Date f Birth Mther s Name Father s Name Parent Cncerns - Please explain any ther cncerns r questins yu have abut yur child Des yur child have any allergies? Yes
More informationMEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache
MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache Measure Descriptin All patients diagnsed with migraine headache r cervicgenic headache wh had a headache management
More informationUpper airway obstruction (UAO)
Printed cpies f this dcument may nt be up t date, btain the mst recent versin frm www.cats.nhs.uk Children s Acute Transprt Service Clinical Guidelines Upper airway bstructin (UAO) Dcument Cntrl Infrmatin
More informationMEDICATION GUIDE. (fingolimod) capsules
MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the
More informationMedical History. hallucinations? 27 Would you describe your sleep as refreshing? 28 Do you need a minimum amount of sleep to feel
Pediatric Neurlgy Pediatric Pulmnlgy Pediatric and Adult Sleep Medicine The Offices f Dr. Jshua Rtenberg, Dr. Sarat Susarla, Dr. Michelle Nwsu, & Rebekah Mats, DNP, FNP-BC Medical Histry Patient Name:
More informationTop 10 Causes of Disability
Tp 10 Causes f Disability Disability can happen t anyne, f any age. Thugh sme may be the result f accidents r injuries that are unavidable, many disabilities are the result f diseases and health cnditins
More informationCONSUMER MEDICINE INFORMATION
CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers sme cmmn questins abut CEFTRIAXONE lcp. It des nt cntain all the available infrmatin. It des nt take the place f talking t yur
More informationSOCIETY FOR PEDIATRIC SEDATION 2209 Dickens Rd., Richmond, VA (804) Fax: (804)
SPS SOCIETY FOR PEDIATRIC SEDATION safe and sund SOCIETY FOR PEDIATRIC SEDATION 2209 Dickens Rd., Richmnd, VA 23230-2005 (804) 565-6354 Fax: (804) 282-0090 www.pedsedatin.rg 1. SKILLS A. Pre-Sedatin Physical
More informationSLEEP-WAKE QUESTIONNAIRE
Shasta Critical Care Specialists Sleep Center: (530) 232-3017, 2701 Old Eureka Way, Suite 1J, Redding, CA 96001 Office: (530) 232-3000, 2701 Old Eureka Way, Suite 1E, Redding, CA 96001 Fax: (530) 242-8545
More informationALCAT FREQUENTLY ASKED QUESTIONS
1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age
More informationInjury, Incident & Illness Procedure
Injury, Incident & Illness Prcedure Injury / Incident Includes any child, adult, r emplyee injured n site. A first aid kit will be available at all times. It will be maintained in accrdance with criterin
More informationBANKMED MEDICAL SCHEME. MEDICINE ADVISORY SERVICES (Chronic Medicine Benefit) GENERAL INFORMATION
BANKMED MEDICAL SCHEME MEDICINE ADVISORY SERVICES (Chrnic Medicine Benefit) GENERAL INFORMATION LIST OF CHRONIC CONDITIONS Cnditins cvered under Bankmed s chrnic medicatin benefit are detailed belw. REGISTRATION
More information<Date> <Group> <Address1> <Address2> <City> <State> <zip> RE: 2015 Blue Physician Recognition (BPR) Program. Dear <Group>:
Three Penn Plaza East Newark, NJ 07105-2200 HriznBlue.cm RE: 2015 Blue Physician Recgnitin (BPR) Prgram Dear : Hrizn Blue Crss Blue Shield
More informationE.M. is an 18 month old healthy appearing Caucasian female who presented to the clinic for a
Kallendrf-SOAP #1 nte S: (Subjective data) E.M. Pt number 188 18 mnth 15 days ld Caucasian female Infrmant B.M.-mther L.M.- father CC We brught her in fr a rutine checkup -B.M. HPI E.M. is an 18 mnth ld
More informationMEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID?
MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidmide) capsules What is the mst imprtant infrmatin I shuld knw abut REVLIMID? Befre yu begin taking REVLIMID, yu must read and agree t all f the instructins
More information454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place
MEDICATION GUIDE ZUBSOLV (Zub-slve) (buprenrphine and nalxne) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away frm children. Accidental use by a child is a medical emergency and
More informationPercutaneous Nephrolithotomy (PCNL)
Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this
More informationHealth Screening Record: Entry Level Due: August 1st MWF 150 Entry Year
Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic
More informationWHAT IS HEAD AND NECK CANCER FACT SHEET
WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationQ 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?
updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health
More informationZika Virus. Where has Zika virus been found? Zika in the United States and its territories:
Where has Zika virus been fund? Zika Virus Prir t 2015, Zika virus utbreaks have ccurred in areas f Africa, Sutheast Asia, and the Pacific Islands. In May 2015, the Pan American Health Organizatin (PAHO)
More informationdecreased when the man lies down. The varicocele cannot usually be palpated lying down.
Variccele - Management View full scenari Hw d I knw my patient has a variccele? The man may present with cncern abut scrtal swelling r scrtal pain, r a variccele may be an incidental finding n physical
More informationTriumeq (abacavir, dolutegravir and lamivudine) Product Backgrounder for US Media
Triumeq (abacavir, dlutegravir and lamivudine) Prduct Backgrunder fr US Media What is Triumeq and wh is Triumeq fr? Triumeq (abacavir 600mg, dlutegravir 50mg and lamivudine 300mg) is the first dlutegravir-based
More informationPediatric and adolescent preventive care and HEDIS *
Pediatric and adlescent preventive care and HEDIS * * HEDIS is a registered trademark f the Natinal Cmmittee fr Quality Assurance (NCQA). UniCare Health Plan f West Virginia, Inc. Healthcare Effectiveness
More informationIAEM Clinical Guideline 12 Foreign Bodies: The Emergency Department Management of Inhaled and Inserted Objects in Children
IAEM Clinical Guideline 12 Freign Bdies: The Emergency Department Management f Inhaled and Inserted Objects in Children Versin 1 August 2018 Authr: Dr Susan Uí Bhrin Adapted with Permissin frm the Jint
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationOpioid Analgesics PA Request Provider Checklist
WVP Health Authrity Updated 05-12-2015 Opiid Analgesics PA Request Prvider Checklist *** If pssible, please include the fllwing infrmatin with PA requests fr piid analgesics. Including the requested infrmatin
More informationPackage leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin Graduated Syringe 10,000 IU/ml Slutin fr Injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationCONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW
FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent
More informationFor more information or to provide feedback on this or any other decision support tool,
Fr mre infrmatin r t prvide feedback n this r any ther decisin supprt tl, email certifiedpractice@crnbc.ca ADULT CONJUNCTIVITIS DEFINITION Inflammatin and erythema f the cnjunctiva, caused by hyperemia
More informationContinuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator
Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results
More informationDRAFT Policy for the Management of Ear Wax
Clinical Cmmissining Grup (CCG) Treatment Plicy NHS Birmingham and Slihull Clinical Cmmissining Grup NHS Sandwell and West Birmingham Clinical Cmmissining Grup DRAFT Plicy fr the Management f Ear Wax 1
More informationMEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV
MEDICATION GUIDE QSYMIA (Ky sim ee uh) (phentermine and tpiramate extended-release) Capsules CIV Read this Medicatin Guide befre yu start taking Qsymia and each time yu get a refill. There may be new infrmatin.
More informationTrillium and Willamette Dental Group: Dental-Medical Diabetes Management and Care Coordination
Trillium and Willamette Dental Grup: Dental-Medical Diabetes Management and Care Crdinatin Grant Prpsal Willamette Dental Grup (WDG) was awarded $117,024 as part f Trillium s Transfrmatin Grant Prgram:
More informationAppendix 1 Example of Homely Remedy Policy
Appendix 1 Example f Hmely Remedy Plicy Hmely Remedy Plicy - EXAMPLE This plicy applies t (insert name f Care Hme) Definitin A hmely (r husehld) remedy is a medicinal prduct fr the shrt-term treatment
More informationIntravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion
Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.
More information3. After I.V. or S.C. administration, onset is rapid, usually within 30 seconds, with duration of 5 to 10 minutes.
Ketamine (Lw Dse): Cntinuus Intravenus Infusin Related Standards & Resurces 1. Parenteral Drug Therapy Manual Mngraphs - Ketamine Skill Level: Advanced skill: Registered Nurses knwledgeable abut pharmaclgy,
More informationAdvantage EAP Employee Assistance Program
Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse
More informationMedication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)
Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause
More informationNEW PATIENT QUESTIONNAIRE-ADULT
3700 WASHINGTON AVENUE EVANSVILLE, IN 47750 (812) 485-7680 NEW PATIENT QUESTIONNAIRE-ADULT PART 1. PATIENT INFORMATION Name Hme Phne Date f Birth Scial Security Number Wrk Phne Tday s Date Physicians Caring
More informationPackage leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate
Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant
More informationΕπείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα
Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα Γ. Λάζαρος Επιμελητής Α Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν.Α The nrmal pericardium is
More information